| molecular function |
|---|
| | GO:0003779 | | actin binding | | Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments. |
| | GO:0005509 | | calcium ion binding | | Interacting selectively and non-covalently with calcium ions (Ca2+). |
| | GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| | GO:0045159 | | myosin II binding | | Interacting selectively and non-covalently with a class II myosin, any member of the class of 'conventional' double-headed myosins that includes muscle myosin. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0019904 | | protein domain specific binding | | Interacting selectively and non-covalently with a specific domain of a protein. |
| biological process |
|---|
| | GO:0051693 | | actin filament capping | | The binding of a protein or protein complex to the end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits. |
| | GO:0030041 | | actin filament polymerization | | Assembly of actin filaments by the addition of actin monomers to a filament. |
| | GO:0090527 | | actin filament reorganization | | A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of actin filaments. |
| | GO:0051014 | | actin filament severing | | The process in which an actin filament is broken down into smaller filaments. |
| | GO:0045010 | | actin nucleation | | The initial step in the formation of an actin filament, in which actin monomers combine to form a new filament. Nucleation is slow relative to the subsequent addition of more monomers to extend the filament. |
| | GO:0008154 | | actin polymerization or depolymerization | | Assembly or disassembly of actin filaments by the addition or removal of actin monomers from a filament. |
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:1990000 | | amyloid fibril formation | | The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. An example of this is seen when human RIP1 and RIP3 kinases form a heterodimeric functional amyloid signaling complex (PMID:22817896). |
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0051016 | | barbed-end actin filament capping | | The binding of a protein or protein complex to the barbed (or plus) end of an actin filament, thus preventing the addition, exchange or removal of further actin subunits. |
| | GO:0030030 | | cell projection organization | | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a cell, e.g. a flagellum or axon. |
| | GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| | GO:0071276 | | cellular response to cadmium ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| | GO:0060271 | | cilium assembly | | The assembly of a cilium, a specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface. Each cilium is bounded by an extrusion of the cytoplasmic membrane, and contains a regular longitudinal array of microtubules, anchored basally in a centriole. |
| | GO:0022617 | | extracellular matrix disassembly | | A process that results in the breakdown of the extracellular matrix. |
| | GO:0097284 | | hepatocyte apoptotic process | | Any apoptotic process in a hepatocyte, the main structural component of the liver. |
| | GO:0046597 | | negative regulation of viral entry into host cell | | Any process that stops, prevents, or reduces the frequency, rate or extent of the entry of viral entry into a host cell. |
| | GO:0014003 | | oligodendrocyte development | | The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system. |
| | GO:0006911 | | phagocytosis, engulfment | | The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis. |
| | GO:0048015 | | phosphatidylinositol-mediated signaling | | A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
| | GO:0051127 | | positive regulation of actin nucleation | | Any process that activates or increases the frequency, rate or extent of actin nucleation, the initial step in the formation of an actin filament in which actin monomers combine to form a new filament. |
| | GO:2001269 | | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. |
| | GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:1902174 | | positive regulation of keratinocyte apoptotic process | | Any process that activates or increases the frequency, rate or extent of keratinocyte apoptotic process. |
| | GO:1903923 | | positive regulation of protein processing in phagocytic vesicle | | Any process that activates or increases the frequency, rate or extent of protein processing in phagocytic vesicle. |
| | GO:0031648 | | protein destabilization | | Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. |
| | GO:0030155 | | regulation of cell adhesion | | Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix. |
| | GO:1903903 | | regulation of establishment of T cell polarity | | Any process that modulates the frequency, rate or extent of establishment of T cell polarity. |
| | GO:1903906 | | regulation of plasma membrane raft polarization | | Any process that modulates the frequency, rate or extent of plasma membrane raft polarization. |
| | GO:0071801 | | regulation of podosome assembly | | Any process that modulates the frequency, rate or extent of podosome assembly. |
| | GO:1903909 | | regulation of receptor clustering | | Any process that modulates the frequency, rate or extent of receptor clustering. |
| | GO:1903689 | | regulation of wound healing, spreading of epidermal cells | | Any process that modulates the frequency, rate or extent of wound healing, spreading of epidermal cells. |
| | GO:0097017 | | renal protein absorption | | A renal system process in which proteins are taken up from the collecting ducts, glomerulus and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures (e.g. protein absorption is observed in nephrocytes in Drosophila, see PMID:23264686). |
| | GO:0045471 | | response to ethanol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus. |
| | GO:0051593 | | response to folic acid | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a folic acid stimulus. |
| | GO:0042989 | | sequestering of actin monomers | | The selective interaction of actin monomers with specific molecules that inhibit their polymerization by preventing their access to other monomers. |
| | GO:0014891 | | striated muscle atrophy | | A process, occurring in striated muscle, that is characterized by a decrease in protein content, fiber diameter, force production and fatigue resistance in response to different conditions such as starvation, aging and disuse. |
| | GO:0042246 | | tissue regeneration | | The regrowth of lost or destroyed tissues. |
| | GO:0016192 | | vesicle-mediated transport | | A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane. |
| | GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
| cellular component |
|---|
| | GO:0030478 | | actin cap | | Polarized accumulation of cytoskeletal proteins (including F-actin) and regulatory proteins in a cell. An example of this is the actin cap found in Saccharomyces cerevisiae. |
| | GO:0015629 | | actin cytoskeleton | | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. |
| | GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| | GO:0030864 | | cortical actin cytoskeleton | | The portion of the actin cytoskeleton, comprising filamentous actin and associated proteins, that lies just beneath the plasma membrane. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005856 | | cytoskeleton | | Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| | GO:0030027 | | lamellipodium | | A thin sheetlike process extended by the leading edge of a migrating cell or extending cell process; contains a dense meshwork of actin filaments. |
| | GO:0043209 | | myelin sheath | | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0048471 | | perinuclear region of cytoplasm | | Cytoplasm situated near, or occurring around, the nucleus. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0002102 | | podosome | | An actin-rich adhesion structure characterized by formation upon cell substrate contact and localization at the substrate-attached part of the cell, contain an F-actin-rich core surrounded by a ring structure containing proteins such as vinculin and talin, and have a diameter of 0.5 mm. |
| | GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
| | GO:0001726 | | ruffle | | Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork. |
| | GO:0016528 | | sarcoplasm | | The cytoplasm of a muscle cell; includes the sarcoplasmic reticulum. |
Description
